Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Zhu

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Urologic Oncology|July 23, 2019
Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancerJason Zhu, Matthew Tucker, Daniele Marin, et al.
Urology Practice|May 5, 2023
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care SystemJames T Kearns, Justin T Matulay, William E Anderson, et al.
Journal for Immunotherapy of Cancer|March 30, 2020
Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinomaMatthew Kyle Labriola, Jason Zhu, Rajan T Gupta, et al.
Translational Andrology and Urology|March 14, 2023
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancerJason Zhu, Chad Livasy, Erin E Donahue, et al.
Organic Letters|September 8, 2012
Efficient and scalable enantioselective synthesis of a CGRP antagonistDavid K Leahy, Yu Fan, Lopa V Desai, et al.
Urology|January 7, 2022
Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate CancerEmily Roebuck, Wei Sha, Caroline D Lu, et al.
Cancer Medicine|July 5, 2019
Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancerMatthew D Tucker, Jason Zhu, Daniele Marin, et al.
Urologic Oncology|June 6, 2022
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomesEarle F Burgess, J Alexa Sanders, Chad Livasy, et al.
Clinical Genitourinary Cancer|June 3, 2020
PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial CarcinomaLandon C Brown, Jason Zhu, Matthew K Labriola, et al.
Translational Andrology and Urology|August 25, 2021
Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patientsJ Alexa Sanders, Connor Frasier, Justin T Matulay, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Urologic Oncology|July 23, 2019
Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancerJason Zhu, Matthew Tucker, Daniele Marin, et al.
Urology Practice|May 5, 2023
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care SystemJames T Kearns, Justin T Matulay, William E Anderson, et al.
Journal for Immunotherapy of Cancer|March 30, 2020
Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinomaMatthew Kyle Labriola, Jason Zhu, Rajan T Gupta, et al.
Translational Andrology and Urology|March 14, 2023
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancerJason Zhu, Chad Livasy, Erin E Donahue, et al.
Organic Letters|September 8, 2012
Efficient and scalable enantioselective synthesis of a CGRP antagonistDavid K Leahy, Yu Fan, Lopa V Desai, et al.
Urology|January 7, 2022
Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate CancerEmily Roebuck, Wei Sha, Caroline D Lu, et al.
Cancer Medicine|July 5, 2019
Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancerMatthew D Tucker, Jason Zhu, Daniele Marin, et al.
Urologic Oncology|June 6, 2022
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomesEarle F Burgess, J Alexa Sanders, Chad Livasy, et al.
Clinical Genitourinary Cancer|June 3, 2020
PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial CarcinomaLandon C Brown, Jason Zhu, Matthew K Labriola, et al.
Translational Andrology and Urology|August 25, 2021
Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patientsJ Alexa Sanders, Connor Frasier, Justin T Matulay, et al.
Pageof 7